Introduction

Sanofi Genzyme is a global business unit of Sanofi that specializes in rare diseases, multiple sclerosis, immunology, and oncology. Their mission is to help individuals with challenging and complex conditions that are often difficult to diagnose and treat. The company is committed to discovering and advancing new therapies to provide hope to patients and their families worldwide. Genzyme became a part of Sanofi in 2011 and has since expanded its focus to include multiple sclerosis, oncology, and immunology. Their approach is shaped by a long history of developing highly specialized treatments and building strong relationships with physician and patient communities. Founded in 1981, Genzyme quickly became one of the world's leading biotechnology companies, known for its pioneering work in treating rare genetic disorders and innovative contributions to medical science and biomanufacturing.